What is the recommended management of septic shock in an adult patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Septic Shock

Immediately initiate aggressive resuscitation with at least 30 mL/kg of IV crystalloid fluid within the first 3 hours, start norepinephrine as the first-line vasopressor to target a mean arterial pressure of 65 mmHg, and administer broad-spectrum antibiotics within 1 hour of recognition after obtaining blood cultures. 1

Initial Recognition and Resuscitation

Septic shock is a medical emergency requiring immediate action. The first 3 hours are critical:

  • Fluid resuscitation: Administer at least 30 mL/kg of crystalloid fluid within the first 3 hours 1. Use balanced crystalloids (such as lactated Ringer's) over normal saline when available 1. Some patients will require more rapid administration and greater volumes.

  • Reassess frequently: After initial fluid bolus, continue fluid administration only as long as hemodynamic parameters improve. Use dynamic variables (pulse pressure variation, stroke volume variation) over static variables to predict fluid responsiveness 1.

  • Lactate measurement: Obtain initial lactate levels and target normalization during resuscitation 1, 2.

Source Control and Antimicrobial Therapy

Before starting antibiotics (but without delaying them more than 45 minutes):

  • Obtain at least 2 sets of blood cultures—one drawn percutaneously and one through vascular access devices if present 1, 2
  • Perform imaging studies promptly to identify infection source 3

Antibiotic administration:

  • In septic shock: Start broad-spectrum IV antimicrobials within 1 hour of recognition 1, 3
  • Remove infected intravascular devices promptly after establishing alternative access 1
  • Implement source control interventions (drainage, debridement) as soon as medically and logistically practical 1

Vasopressor Management

First-line vasopressor:

  • Norepinephrine is the first-choice vasopressor, targeting MAP ≥65 mmHg 1
  • Place an arterial catheter as soon as practical for accurate blood pressure monitoring 1

Second-line agents (when MAP target not achieved with norepinephrine alone):

  • Add vasopressin at 0.03 units/minute (not to exceed 0.03-0.04 units/min) to raise MAP or decrease norepinephrine dose 1
  • Alternatively, add epinephrine if additional agent needed 1

Agents to avoid or use only in specific circumstances:

  • Dopamine: Use only in highly selected patients with low risk of tachyarrhythmias and absolute or relative bradycardia 1
  • Low-dose dopamine: Do NOT use for renal protection 1
  • Phenylephrine: Not recommended except when norepinephrine causes serious arrhythmias, cardiac output is high with persistently low blood pressure, or as salvage therapy 1

Inotropic Support

Add dobutamine (up to 20 μg/kg/min) when:

  • Evidence of myocardial dysfunction with elevated cardiac filling pressures and low cardiac output, OR
  • Ongoing signs of hypoperfusion despite adequate fluid resuscitation and MAP ≥65 mmHg 1

Titrate to endpoints reflecting perfusion; reduce or discontinue if worsening hypotension or arrhythmias develop 1.

Corticosteroid Therapy

Do NOT routinely use IV hydrocortisone if adequate fluid resuscitation and vasopressor therapy restore hemodynamic stability 1, 3, 1.

Consider hydrocortisone 200 mg/day only when:

  • Hemodynamic stability cannot be achieved despite adequate fluids and vasopressors 1, 3, 1
  • Taper when vasopressors are no longer required 1, 3, 1
  • Use continuous infusion rather than bolus dosing 1, 3, 1

Do NOT use ACTH stimulation testing to guide corticosteroid decisions 1, 3, 1.

Fluid Selection: Critical Distinctions

Use crystalloids as the fluid of choice for initial and subsequent resuscitation 1:

  • Balanced crystalloids or saline are both acceptable, though balanced crystalloids may be preferred 1

Consider albumin only when patients require substantial amounts of crystalloids 1

Strongly AVOID:

  • Hydroxyethyl starches (HES): Increased risk of acute kidney injury and need for renal replacement therapy 1, 3
  • Use crystalloids over gelatins 1

Blood Product Management

Once tissue hypoperfusion resolves:

  • Transfuse RBCs only when hemoglobin <7.0 g/dL, targeting 7.0-9.0 g/dL (unless myocardial ischemia, severe hypoxemia, or acute hemorrhage present) 1
  • Do NOT use fresh frozen plasma to correct laboratory clotting abnormalities without bleeding or planned procedures 1
  • Do NOT use antithrombin or erythropoietin 1

Common Pitfalls to Avoid

  1. Delaying vasopressors: Don't wait to achieve "adequate" fluid resuscitation before starting norepinephrine if severe hypotension persists. Early vasopressor use prevents fluid overload 3, 4.

  2. Excessive fluid administration: The 30 mL/kg is a minimum initial bolus, not a mandate to continue fluids regardless of response. Stop fluids when hemodynamic improvement plateaus 1.

  3. Using dopamine as first-line: Norepinephrine has superior outcomes; dopamine increases arrhythmia risk 1, 3.

  4. Routine corticosteroid use: Only indicated when shock remains refractory to fluids and vasopressors 1, 3, 1.

  5. Delaying antibiotics for "perfect" cultures: Obtain cultures quickly but never delay antibiotics beyond 1 hour in septic shock 1, 3.

The evidence supporting these recommendations comes primarily from the 2016 Surviving Sepsis Campaign guidelines 1, which represent the most comprehensive and authoritative guidance available, with strong recommendations based on moderate-to-high quality evidence for fluid resuscitation, norepinephrine as first-line vasopressor, and early antimicrobial therapy.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.